Gustavo Monnerat, Deputy Editor at The Lancet, shared a post on LinkedIn:
“Bordeaux. On how to evaluate AI in clinical trials, the question that will define the next decade of medicine.
I was at the inaugural AI in Clinical Trials Symposium, hosted by The George Institute for Global Health and the University Bordeaux.
MAIN POINTS:
- AI is moving into every stage of trials, design, recruitment, monitoring, analysis, regulatory decisions, and publshing.
BEST PART OF THE EVENT:
- One room, every perspective: academics, regulators, industry, journals, and patient advocates, all pushing on the same questions from different sides.”
Other articles about AI on OncoDaily.